Express & Expedited Shipping Service
USD $36.86
IndiaCOMBIGAN 0.2/0.5% is a prescription eye drop solution used to manage elevated intraocular pressure in patients with ocular hypertension or glaucoma. It combines two active ingredients, brimonidine tartrate and timolol maleate, which work together to reduce pressure in the eye.
COMBIGAN 0.2/0.5% works by reducing the amount of fluid produced in the eye and increasing the outflow of this fluid. Brimonidine tartrate is an alpha-2 adrenergic receptor agonist, while timolol maleate is a beta-blocker. Together, they help lower intraocular pressure effectively.
COMBIGAN 0.2/0.5% is intended for patients diagnosed with elevated intraocular pressure due to ocular hypertension or glaucoma. It is essential to use this medication under the guidance of a healthcare professional.
Administer COMBIGAN 0.2/0.5% as directed by your healthcare provider. Typically, the recommended dosage is one drop in the affected eye(s) twice daily, approximately 12 hours apart. Follow the instructions provided by your doctor or pharmacist carefully.
Common side effects may include eye redness, burning or stinging sensation, dry mouth, and fatigue. If you experience severe side effects such as vision changes, eye pain, or symptoms of an allergic reaction, seek medical attention promptly.
Before using COMBIGAN 0.2/0.5%, inform your healthcare provider about any medical conditions, allergies, or medications you are currently taking. This product may not be suitable for individuals with certain respiratory conditions, heart problems, or allergies to its ingredients.
If you are using other eye medications, wait at least 5 minutes between administering COMBIGAN 0.2/0.5% and other eye drops. Consult your healthcare provider for specific guidance on combining treatments.
Store COMBIGAN 0.2/0.5% at room temperature, away from light and moisture. Keep the bottle tightly closed when not in use, and do not touch the dropper tip to any surface to avoid contamination.
For more detailed information about COMBIGAN 0.2/0.5%, consult the product's prescribing information or speak with your healthcare provider. They can provide personalized advice based on your specific medical needs.
Health Guides
Nov 06, 2026
Medication dry mouth happens when a drug reduces saliva production or alters the sensation of moisture. Anticholinergic effects are a common cause, and management usually combines a medication review, moisture replacement and tooth protection. Persistent dryness can make eating or speaking difficult
Nov 05, 2026
Blood pressure medicines can cause dizziness on standing because they reduce the body's ability to maintain pressure against gravity. The resulting drop can briefly reduce blood flow to the brain, a condition called orthostatic hypotension. Blood pressure medication dizziness often appears after t
Nov 04, 2026
Biotin supplements can interfere with thyroid and heart blood tests, producing falsely high or unexpectedly low results. This interference affects certain laboratory methods rather than the actual hormone or cardiac-marker concentration being measured. The greatest danger is a falsely low troponin r
Nov 02, 2026
ADHD medication monitoring tracks blood pressure, heart rate, body mass, appetite and sleep before treatment, during dose adjustments and throughout long-term care. For adults, NICE recommends pulse and blood pressure checks before and after each dose change, then every six months. The aim is to pre
Nov 01, 2026
Baricitinib safety depends on infection screening, blood tests, and prompt evaluation of new symptoms. The main concerns are serious infections, shingles, blood clots, cancer, and cardiovascular events. Blood counts, liver and kidney function, and cholesterol help guide treatment. Historical rheumat
Oct 31, 2026
Whether to repeat a dose of an oral medication depends on the medicine, formulation, and elapsed time. Vomiting within 15 minutes or seeing an intact tablet can justify considering a replacement; after an hour, another dose is usually unnecessary. These are general timing guides, not permission to r
Oct 30, 2026
Tacrolimus monitoring measures the tacrolimus level in whole blood to help balance organ rejection prevention against drug-related toxic effects. The result is useful only when interpreted against the dose and formulation. A routine trough sample is collected immediately before the next dose, usuall
Oct 29, 2026
Serotonin syndrome is a potentially life-threatening drug reaction caused by excessive serotonin activity. Fever, confusion, and muscle jerking after a medicine change require urgent medical assessment. Symptoms often begin within hours, particularly when medicines with overlapping serotonin effects
Oct 28, 2026
Lithium monitoring combines timed blood levels with kidney, thyroid, and calcium tests to keep bipolar treatment effective and reduce toxicity risk. Testing starts before treatment and continues throughout it. Lithium has a narrow therapeutic index, so relatively small changes in blood concentration
Oct 27, 2026
Benign prostatic hyperplasia (BPH) is a noncancerous enlarged prostate. Alpha blockers ease urinary symptoms by relaxing muscle around the outlet, often within days to weeks. 5-alpha-reductase inhibitors (5-ARIs) shrink the prostate gradually and can reduce the risks of urinary retention and surgery
